• Policy
• Drug substances with impurities are collected voluntarily
• by Lee, Tak-Sun Sep 16, 2021 05:59am

• Company
• Idiance reveals the results of Venadaparib
• by Kim, Jin-Gu Sep 16, 2021 05:59am

• Policy
• 299 items were voluntarily withdrawn
• by Lee, Hye-Kyung Sep 15, 2021 06:12am

• Company
• Novartis Korea appoints Byungjae Yoo as new head
• by Eo, Yun-Ho Sep 15, 2021 06:11am

• Company
• Pharma companies fail to suspend renegotiations for CAs
• by Chon, Seung-Hyun Sep 15, 2021 06:11am

• InterView
• Leclaza’s ESMO data will determine FDA approval
• by An, Kyung-Jin Sep 15, 2021 06:11am

• Policy
• Controversy over the price of COVID PO of ₩900,000
• by Lee, Jeong-Hwan Sep 15, 2021 06:11am

• Company
• Who is the winner of the domestic toxin in the US market?
• by Nho, Byung Chul Sep 14, 2021 05:55am

• Policy
• Sama Pharm’s ‘Daxas’ generic approved
• by Lee, Tak-Sun Sep 14, 2021 05:55am

• Policy
• Moon "Invest ₩2.2 trillion in 5 years for vaccines"
• by Lee, Tak-Sun Sep 14, 2021 05:55am